Evaluating the effectiveness of a Diabetes Needs Assessment Tool (DNAT): a randomised controlled trial
| ISRCTN | ISRCTN67215088 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN67215088 |
| Protocol serial number | N/A |
| Sponsor | BMJ Group (UK) |
| Funders | Merck Sharp and Dohme Regional Business Support Center (MSD RBSC) GmbH (Germany) - involved in design of study but no access to data or statistical analyses, BMJ Group (UK) - not involved in statistical analyses |
- Submission date
- 29/01/2009
- Registration date
- 30/01/2009
- Last edited
- 11/01/2018
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nutritional, Metabolic, Endocrine
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
Cardiff Medicentre
Heath Park
Cardiff
CF14 4UJ
United Kingdom
| Phone | +44 (0)2920 757744 |
|---|---|
| DJenkins@bmjgroup.com |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Multicentre randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Evaluating the effectiveness of using a Diabetes Needs Assessment Tool (DNAT) on health professionals' knowledge of diabetes and self-reported changes in clinical practice: a randomised controlled trial |
| Study objectives | Amended as of 26/03/2009: Aims: 1. To evaluate the effectiveness of using a new online Diabetes Needs Assessment Tool (DNAT) to improve knowledge of how to manage diabetes 2. To evaluate the acceptability of this format of learning 3. To evaluate self-reported changes in clinical practice as a result of this learning Hypotheses: 1. Four months after being administered the online learning materials, learners in the intervention group will show greater diabetes knowledge and report higher levels of acceptability of the learning materials than learners in the control group 2. Five months after being administered the online learning materials, learners in the intervention group will report more changes to their clinical practice than learners in the control group Initial information at the time of registration: Aims: 1. To evaluate the effectiveness of using a new online Diabetes Needs Assessment Tool (DNAT) to improve knowledge of how to manage diabetes 2. To evaluate the acceptability of this format of learning 3. To evaluate self-reported changes in clinical practice as a result of this learning Hypotheses: 1. Four months after being administered the online learning materials, learners in the intervention group will show greater knowledge change and report higher levels of acceptability of the learning materials than learners in the control group 2. Five months after being administered the online learning materials, learners in the intervention group will report more changes to their clinical practice than learners in the control group |
| Ethics approval(s) | As of 11/02/2009 the REC for Wales has confirmed that the study does not require full ethical review |
| Health condition(s) or problem(s) studied | Diabetes |
| Intervention | Both the control group and the intervention group will be given access to the same online Diabetes Learning Modules during a 4-month learning period. The Diabetes Learning Modules include: 1. Current evidence-based guidelines (particularly those of the European Society of Cardiology and the European Association for the Study of Diabetes [ESC-EASD] Guidelines on Diabetes, Pre-diabetes and Cardiovascular Disease) 2. Important clinical areas and common difficulties in practice 3. Type 1, Type 2, diabetes in pregnancy and secondary causes of diabetes All content of these learning modules is applicable to European practice and material comes from BMJ Learning, Elsevier Health Sciences and the International Diabetes Federation. In addition to the Diabetes Learning Modules, the intervention group will be administered the Diabetes Needs Assessment Tool (DNAT). The DNAT is a computerised adaptive test comprised of clinically rich case problems. On completion of the DNAT, a personalised learning report is created for each learner identifying their learning needs alongside individualised recommendations of the most appropriate Diabetes Learning Modules to meet those needs. At any stage this personalised report can be viewed listing the performance of the learner at that point. |
| Intervention type | Other |
| Primary outcome measure(s) |
Amended as of 26/03/2009: |
| Key secondary outcome measure(s) |
1. Acceptability of the learning materials measured by an electronic survey 4 months after being administered the learning materials |
| Completion date | 25/09/2009 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 200 |
| Key inclusion criteria | Participants must be either English or German speaking practising doctors or nurses (approximately 20 - 65 years, either sex) managing at least one patient with diabetes a week. |
| Key exclusion criteria | Doctors and nurses not managing at least one patient with diabetes a week. |
| Date of first enrolment | 06/02/2009 |
| Date of final enrolment | 25/09/2009 |
Locations
Countries of recruitment
- United Kingdom
- Wales
- Germany
Study participating centre
CF14 4UJ
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 16/06/2011 | Yes | No | |
| Protocol article | protocol | 30/07/2009 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
11/01/2018: publication ref added.